CAT# | PPO-H009 |
Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
Purity | >70% (HPLC-MS) |
Size | 1 vial containing 15 nmol ( 25μg) per peptide | SwissProt ID | Q04360 | Format | Freeze dried in amber type glass vial | Topics | Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sj?gren's syndrome, Multiple sclerosis | NumberOfPeptides | 117 | Organism | Epstein-Barr virus (HHV-4) | Specifications | Peptide scan (15mers with 11 aa overlap) | Protein Length | 479 | Protein Name | BMLF1 (mRNA export factor EB2) | References | 1."PepMixTM Peptide Pools for Clinical Applications: T cell therapy for viral infections after hematopoietic stem cell transplant" Leen et al, Application Note (2012) 2."Rebound of Residual Plasma Viremia After Initial Decrease Following Addition of Intravenous Immunoglobulin to Effective Antiretroviral Treatment of HIV". Mellberg et al., AIDS Research and Therapy (2011)) 3."A Whole Blood Monokine-based Reporter Assay Provides a Sensitive and Robust Measurement of the Antigen-Specific T Cell Response" Chakera et al., Journal of Translational Medicine (2011) 4."Effective and Long-term Control of EBV PTLD After Transfer of Peptide-Selected T Cells". Moosmann et al., BLOOD (2010) |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
PPO-H146 | Influenza A (Neuraminidase/Turkey/1/2005(H5N1)) | Inquiry | ||
PPO-H029 | HCMVA (UL151) | Inquiry | ||
PPO-H002 | BKV (capsid protein VP2) | Inquiry | ||
PPO-H060 | Influenza A (Neuroamidase /California (H1N1) | Inquiry | ||
PPO-H145 | Influenza A (HA/Indonesia (H5N1)) | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×2. Myotropic activity of allatostatins in tenebrionid beetles
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
4. Emu oil in combination with other active ingredients for treating skin imperfections
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Dipeptide diaminobutyroyl benzylamide diacetate, a biologically active polypeptide, classified as a neuropeptide ...
Zonisamide, sold as brand name Zonegran, is a derivative of 3-(sulfamoylmethyl)-l,2-benzisoxazole. It is a membe ...
PT-141, also called as Bremelanotide, is a derivative for Melanotan 2 (M2). Unlike M2, PT-141 lacks C-terminal a ...
Ecallantide, sold under the trade name Kalbitor, is a plasma kallikrein inhibitor, consisting of sixty amino aci ...
Iron chelating agent is a new type of iron-removing treatment based on the combination of directional and in viv ...